Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial

  1. Hungria, V.
  2. Beksac, M.
  3. Weisel, K.C.
  4. Nooka, A.K.
  5. Masszi, T.
  6. Spicka, I.
  7. Munder, M.
  8. Mateos, M.-V.
  9. Mark, T.M.
  10. Qi, M.
  11. Qin, X.
  12. Fastenau, J.
  13. Spencer, A.
  14. Sonneveld, P.
  15. Garvin, W.
  16. Renaud, T.
  17. Gries, K.S.
Journal:
British Journal of Haematology

ISSN: 1365-2141 0007-1048

Year of publication: 2021

Volume: 193

Issue: 3

Pages: 561-569

Type: Article

DOI: 10.1111/BJH.17321 GOOGLE SCHOLAR

Sustainable development goals